Ultra rapid lispro improves postprandial glucose control compared with lispro in patients with type 1 diabetes: Results from the 26‐week PRONTO‐T1D study

AIMS: To evaluate the efficacy and safety of ultra rapid lispro (URLi) versus lispro in adults with type 1 diabetes in a 26‐week, treat‐to‐target, phase 3 trial. MATERIALS AND METHODS: After an 8‐week lead‐in to optimize basal insulin glargine or degludec, patients were randomized to double‐blind me...

全面介紹

Na minha lista:
書目詳細資料
發表在:Diabetes Obes Metab
Main Authors: Klaff, Leslie, Cao, Dachuang, Dellva, Mary Anne, Tobian, Janet, Miura, Junnosuke, Dahl, Dominik, Lucas, Jean, Bue‐Valleskey, Juliana
格式: Artigo
語言:Inglês
出版: Blackwell Publishing Ltd 2020
主題:
Original Articles
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7539952/
https://ncbi.nlm.nih.gov/pubmed/32488923
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.14100
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍